Abstract
Background: Decompensated diabetes is associated with a higher prevalence and severity of periodontitis and poorer response to periodontal therapy. It is conceivable that periodontal therapy may cause systemic and local complications in this type of patients. The aim of the present study was to identify and describe the best available evidence for the treatment of periodontitis in decompensated diabetics.Material and methods: An expert committee including participants from different areas gathered to discuss and develop a treatment guideline under the guidance of the Cochrane Associate Center, Faculty of Dentistry, University of Chile. In total, four research questions were prepared. The questions prepared related to decompensated diabetic patients (glycated hemoglobin >8) were, (1) Does the exposure to periodontal treatment increase the risk of infectious or systemic complications? (2) Does the antibiotic treatment or prophylaxis, compared to not giving it, reduce infectious complications? (3) Does the exposure to periodontal treatment, compared to no treatment, reduce the glycated hemoglobin levels (HbA1c)? Last question was related to diabetic patients, (4) Does the exposure to a higher level of HbA1c, compared to stable levels, increase the risk of infectious complications? Based on these questions, a search strategy was developed using MEDLINE and EPISTEMONIKOS. Only systematic reviews were considered.Results: For question 1, the search yielded 12 records in EPISTEMONIKOS and 23 in MEDLINE. None of these studies addressed the question. For question 2, the search yielded 58 records in EPISTEMONIKOS and 11 in MEDLINE. None of these studies addressed the question. For question 3, the search yielded 16 records in EPISTEMONIKOS and 11 in MEDLINE. Thirteen addressed the question. For question 4, the search yielded 7 records in EPISTEMONIKOS and 9 in MEDLINE. One addressed the question.Conclusions: In decompensated diabetic patients, there is lack of scientific information about risk of infectious or systemic complications as a result of periodontal treatment and about the impact of antibiotic treatment or prophylaxis on reduction if infectious complications. A defined HbA1c threshold for dental and periodontal treatment in diabetic patients has yet to be determined. Finally, periodontal treatment does have an impact on HbA1c levels.
Highlights
Chronic non-communicable diseases (NCDs) are a worldwide public health issue, and the leading cause of death with an estimated of 41 million deaths per year [1]
The questions prepared related to decompensated diabetic patients were, [1] does the exposure to periodontal treatment increase the risk of infectious or systemic complications? [2] Does the antibiotic treatment or prophylaxis, compared to not giving it, reduce infectious complications? [3] Does the exposure to periodontal treatment, compared to no treatment, reduce the glycated hemoglobin levels (HbA1c)? Last question was related to diabetic patients, [4] Does the exposure to a higher level of HbA1c, compared to stable levels, increase the risk of infectious complications?
When searching studies for the following question: “In decompensated diabetic patients (HbA1c >8%), does the exposure to periodontal treatment increase the risk of infectious or systemic complications?,” a total of 12 systematic reviews was obtained in EPISTEMONIKOS, none of which was relevant for the question asked
Summary
Chronic non-communicable diseases (NCDs) are a worldwide public health issue, and the leading cause of death with an estimated of 41 million deaths per year [1]. In Chile, it is estimated that 22.8% of the population suffers from two or more NCDs. Diabetes is one of the most frequent NCDs in the population, with a prevalence of 382 million worldwide in 2013 that would increase to 592 million in 2035 [2]. Periodontitis has been mentioned as the sixth complication of diabetes, with higher degrees of severity in patients with poor glycemic control of their diabetes [7, 8]. Decompensated diabetes is associated with a higher prevalence and severity of periodontitis and poorer response to periodontal therapy. It is conceivable that periodontal therapy may cause systemic and local complications in this type of patients. The aim of the present study was to identify and describe the best available evidence for the treatment of periodontitis in decompensated diabetics
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.